Literature DB >> 27832585

Tackling Difficult Staphylococcus aureus Infections: Antibodies Show the Way.

Bo Shopsin1, Srini V Kaveri2, Jagadeesh Bayry3.   

Abstract

The recent spread of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) has brought increasing concerns of heightened disease severity and persistence following invasive disease. In line with the need for new treatment paradigms, two recent reports have shown that antibody-based therapies can restrict acute S. aureus infection and persistence and improve pathological symptoms.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IVIG; Immunoglobulin; Panton-Valentine leukocidin; Thiomab; antibiotic; intravenous immunoglobulin; necrotizing pneumonia; phagocytes; rifalogue; α-hemolysin

Mesh：

Substances：

Year:  2016        PMID： 27832585     DOI： 10.1016/j.chom.2016.10.018

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN： 1931-3128            Impact factor:   21.023


  10 in total

1.  Impact of Bacterial Membrane Fatty Acid Composition on the Failure of Daptomycin To Kill Staphylococcus aureus.

Authors:  Rym Boudjemaa; Clément Cabriel; Florence Dubois-Brissonnet; Nicolas Bourg; Guillaume Dupuis; Alexandra Gruss; Sandrine Lévêque-Fort; Romain Briandet; Marie-Pierre Fontaine-Aupart; Karine Steenkeste
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

Review 2.  Natural Antibodies: from First-Line Defense Against Pathogens to Perpetual Immune Homeostasis.

Authors:  Mohan S Maddur; Sébastien Lacroix-Desmazes; Jordan D Dimitrov; Michel D Kazatchkine; Jagadeesh Bayry; Srini V Kaveri
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

3.  Monomeric Immunoglobulin A from Plasma Inhibits Human Th17 Responses In Vitro Independent of FcαRI and DC-SIGN.

Authors:  Chaitrali Saha; Mrinmoy Das; Veerupaxagouda Patil; Emmanuel Stephen-Victor; Meenu Sharma; Sandra Wymann; Monika Jordi; Cédric Vonarburg; Srini V Kaveri; Jagadeesh Bayry
Journal:  Front Immunol       Date:  2017-03-14       Impact factor: 7.561

4.  Human Memory B Cells Targeting Staphylococcus aureus Exotoxins Are Prevalent with Skin and Soft Tissue Infection.

Authors:  Adam J Pelzek; Bo Shopsin; Emily E Radke; Kayan Tam; Beatrix M Ueberheide; David Fenyö; Stuart M Brown; Qianhao Li; Ada Rubin; Yi Fulmer; William K Chiang; David N Hernandez; Hanane El Bannoudi; William E Sause; Alexis Sommerfield; Isaac P Thomsen; Andy O Miller; Victor J Torres; Gregg J Silverman
Journal:  mBio       Date:  2018-03-13       Impact factor: 7.867

Review 5.  Importance of immunoglobulin therapy for COVID-19 patients with lymphocytopenia.

Authors:  Heba K Nabih
Journal:  Bull Natl Res Cent       Date:  2021-02-22

6.  Antibiotic Combined with Epitope-Specific Monoclonal Antibody Cocktail Protects Mice Against Bacteremia and Acute Pneumonia from Methicillin-Resistant Staphylococcus aureus Infection.

Authors:  LianLi Duan; Jinyong Zhang; Zhifu Chen; Qiang Gou; Qingshan Xiong; Yue Yuan; Haiming Jing; Jiang Zhu; Li Ni; Yuling Zheng; Zhiyong Liu; Xiaokai Zhang; Hao Zeng; Quanming Zou; Zhuo Zhao
Journal:  J Inflamm Res       Date:  2021-08-30

7.  A single center experience of intravenous immunoglobulin treatment in Covid-19.

Authors:  Ahmet Omma; Abdulsamet Erden; Berkan Armağan; Serdar Can Güven; Özlem Karakaş; Enes Seyda Şahiner; Deniz Erdem; Seval İzdeş; İhsan Ateş; Orhan Küçükşahin
Journal:  Int Immunopharmacol       Date:  2021-06-14       Impact factor: 5.714

Review 8.  Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients.

Authors:  Srinivasa Reddy Bonam; Srini V Kaveri; Anavaj Sakuntabhai; Laurent Gilardin; Jagadeesh Bayry
Journal:  Cell Rep Med       Date:  2020-04-30

9.  Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients?

Authors:  Samir Jawhara
Journal:  Int J Mol Sci       Date:  2020-03-25       Impact factor: 5.923

Review 10.  COVID-19: benefits and risks of passive immunotherapeutics.

Authors:  Ankur Gupta; Rashmi Karki; Himanshu R Dandu; Kuldeep Dhama; Madan Lb Bhatt; Shailendra K Saxena
Journal:  Hum Vaccin Immunother       Date:  2020-09-22       Impact factor: 3.452
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.